GeneFerm Biotechnology Co Ltd (1796) — Cash Flow Reinvestment Rate
GeneFerm Biotechnology Co Ltd (1796) has a Cash Flow Reinvestment Rate of 8.19x as of June 2025, reinvesting NT$11.86 Million (capex NT$5.98 Million plus investments NT$-5.88 Million) from operating cash flow of NT$1.45 Million. Explore how much does GeneFerm Biotechnology Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
GeneFerm Biotechnology Co Ltd Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for GeneFerm Biotechnology Co Ltd across 8 annual periods. Also explore how large is GeneFerm Biotechnology Co Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for GeneFerm Biotechnology Co Ltd (2017–2024)
Year-by-year capital reinvestment analysis for GeneFerm Biotechnology Co Ltd. For live market cap and broader valuation context, see 1796 company net worth.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 5.63x | NT$45.53 Million | NT$8.09 Million | NT$22.70 Million | ▲ +654.1% |
| 2023 | 0.75x | NT$142.02 Million | NT$190.31 Million | NT$71.40 Million | ▼ -83.6% |
| 2022 | 4.56x | NT$558.75 Million | NT$122.43 Million | NT$278.42 Million | ▲ +76.1% |
| 2021 | 2.59x | NT$290.86 Million | NT$112.23 Million | NT$145.61 Million | ▼ -11.0% |
| 2020 | 2.91x | NT$164.36 Million | NT$56.42 Million | NT$82.32 Million | ▼ -60.9% |
| 2019 | 7.45x | NT$109.43 Million | NT$14.69 Million | NT$54.57 Million | ▲ +437.6% |
| 2018 | 1.39x | NT$58.39 Million | NT$42.14 Million | NT$28.81 Million | ▼ -24.0% |
| 2017 | 1.82x | NT$111.31 Million | NT$61.08 Million | NT$55.16 Million | — |